SNHG22
geneOn this page
Also known as SCARNA17HG
Summary
SNHG22 (small nucleolar RNA host gene 22, HGNC:50285) is a long non-coding RNA gene on chromosome 18q21.1.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:50285 |
| Approved symbol | SNHG22 |
| Name | small nucleolar RNA host gene 22 |
| Location | 18q21.1 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | SCARNA17HG |
| Ensembl gene | ENSG00000267322 |
| Ensembl biotype | lncRNA |
| Entrez | 103091864 |
| RNAcentral | URS00001118C6 — lncRNA, 1615 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 5 lncRNA
ENST00000589499, ENST00000615535, ENST00000617833, ENST00000782330, ENST00000782331
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000589499 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002786192 | 49814023 | 49814062 |
| ENSE00002790890 | 49849637 | 49851059 |
| ENSE00002825025 | 49839276 | 49839364 |
| ENSE00002852967 | 49840363 | 49840425 |
Expression profiles
Bgee: expression breadth ubiquitous, 167 present calls, max score 99.56.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 397.0163 / max 10809.8577, expressed in 1823 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 170242 | 397.0163 | 1823 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 99.56 | gold quality |
| sural nerve | UBERON:0015488 | 98.74 | gold quality |
| bone marrow cell | CL:0002092 | 98.03 | gold quality |
| calcaneal tendon | UBERON:0003701 | 97.69 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 91.59 | gold quality |
| adrenal tissue | UBERON:0018303 | 87.16 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 85.24 | gold quality |
| granulocyte | CL:0000094 | 83.85 | gold quality |
| right lobe of liver | UBERON:0001114 | 83.14 | gold quality |
| left ovary | UBERON:0002119 | 80.76 | gold quality |
| right ovary | UBERON:0002118 | 80.66 | gold quality |
| monocyte | CL:0000576 | 79.99 | gold quality |
| leukocyte | CL:0000738 | 79.89 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 79.42 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 79.06 | gold quality |
| lower esophagus | UBERON:0013473 | 79.01 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 78.57 | gold quality |
| muscle of leg | UBERON:0001383 | 77.81 | gold quality |
| tibial nerve | UBERON:0001323 | 77.26 | gold quality |
| adenohypophysis | UBERON:0002196 | 77.25 | gold quality |
| apex of heart | UBERON:0002098 | 77.10 | gold quality |
| blood | UBERON:0000178 | 76.88 | gold quality |
| ascending aorta | UBERON:0001496 | 76.71 | gold quality |
| tendon | UBERON:0000043 | 76.61 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 76.59 | gold quality |
| liver | UBERON:0002107 | 76.47 | gold quality |
| thoracic aorta | UBERON:0001515 | 76.43 | gold quality |
| body of uterus | UBERON:0009853 | 76.43 | gold quality |
| left uterine tube | UBERON:0001303 | 76.41 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 76.39 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.68 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 6)
- lncRNA SNHG22 sponges miR1283p to promote the progression of colorectal cancer by upregulating E2F3. (PMID:34368861)
- Long non-coding RNA SNHG22 facilitates hepatocellular carcinoma tumorigenesis and angiogenesis via DNA methylation of microRNA miR-16-5p. (PMID:34652260)
- ELK4-mediated lncRNA SNHG22 promotes gastric cancer progression through interacting with EZH2 and regulating miR-200c-3p/Notch1 axis. (PMID:34663788)
- SNHG22 promotes migration and invasion of trophoblasts via miR-128-3p/PCDH11X axis and activates PI3K/Akt signaling pathway. (PMID:35679761)
- LncRNA SNHG22 promotes gastric cancer progression by regulating the miR-101-3p/e2f2 axis. (PMID:36281526)
- Detection of serum SNHG22 and its correlation with prognosis of non-small cell lung cancer. (PMID:39300525)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): microvillus inclusion disease